News & Articles

Strategic agreement unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process

PCR/qPCR solution from Integrated DNA Technologies will support the surveillance and monitoring of the current H5N1 strain of bird flu

Companies unite in shared vision of enabling researchers to translate genomic insights

New ready-to-ship xGen NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow

IDT’s xGen™ NGS solutions now fully support tumor-informed MRD research workflows from library preparation to hybridization capture

Leading genomics solutions provider debuts complete NGS library preparation to support the identification of novel monkeypox variants in response to growing researcher demands for viral surveillance solutions

New system provides end-to-end solution for researchers to validate specificity of CRISPR and other genome editing projects

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19

New product enables high DNA library complexity from low-quality samples at industry-leading conversion rates

Complete qPCR panel of the CDC-published sequences for coronavirus detection in addition to preferred pricing on gBlocks fragments and synthetic genes ordered for vaccine development

Next-generation sequencing discovery pools enable larger custom panels and low sample numbers to speed up discovery

Long, high-yield oligos with low error rate enable researchers to skip amplification steps and start projects immediately

Next-generation sequencing oligo products to be used in groundbreaking food safety platform

New high-performance, cost-effective PACE SNP assays will lower the cost and improve the reliability of SNP or indel screening

Partnership strengthens IDT’s position as an NGS leader in China

Comprehensive, powerful and flexible NGS offering showcased at ESHG

Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications

Reduction of CRISPR off-target effects without significant loss of on-target activity

Expanded CRISPR toolkit includes Cpf1 and range of Alt-R™ support products, increasing the options available to molecular biology researchers